Patient survival after renal transplantation; more than 25 years follow-up

Nephrology Dialysis Transplantation

Volumn 12, Issue 8, 1997, Pages 1672-1679

  Arend, S M ^a   Mallat, M J K ^a   Westendorp, R J W ^a   Van Der Woude, F J ^a   Van Es, L A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Age; Azathioprine; Cyclosporin; Diabetes mellitus; Dialysis; Era; Hypertension; Immunosuppression; Renal transplantation; Survival analysis

Indexed keywords

ADULT; ARTICLE; CADAVER KIDNEY; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MORTALITY; NETHERLANDS; PRIORITY JOURNAL; SURVIVAL;

ADULT; AGE DISTRIBUTION; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATIONS; RENAL REPLACEMENT THERAPY; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 0030845537     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.8.1672     Document Type: Article

References (29)

1. Perez RV, Matas AJ, Gillingham KJ et al. Lessons learned and future hopes: three thousand renal transplants at the University of Minnesota. In: Terasaki PI, Cecka JM (eds). Clinical Transplants 1990. UCLA Press, 1990; 217-231
2. Opelz G. Prognostische Faktoren für den Verlauf nach Nierentransplantation. Urologe 1994; 33: 377-382
3. Hill MN, Grossman RA, Feldman HI, Hurwitz S, Dafoe DC. Changes in causes of death after renal transplantation, 1966 to 1987. Am J Kidney Dis 1991; 17: 512-518
4. Gray JR, Kasiske BL. Patient and renal allograft survival in the late posttransplant period. Semin Nephrol 1992; 12: 343-352
5. Cecka JM, Terasaki PI. Thee UNOS scientific renal transplant registry. In: Terasaki PI, Cecka JM, eds. Clinical Transplants 1994. UCLA Press, 1994; 1-18
6. Tesi RJ, Elkhammas EA, Davies EA, Henry ML, Ferguson RM. Renal transplantation in older people. Lancet 1994; 343: 461-464
7. Helderman JH. Transplantation and the elderly. Nephrol Dial Transplant 1995; 10: 773-774. [editorial]
8. Briggs JD. Should older patients receive renal transplants? Nephrol Dial Transplant 1995; 10: 18-20
9. Kootte AMM, Lensen LM, van Es LA, Paul LC. Controlled cyclosporine conversion at three months after renal transplantation. Transplantation 1988; 46: 677-680
10. Hollander AAMJ, van Saase JLCM, Kootte AMM et al. Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation. Lancet 1995; 345: 610-614
11. Frei U, Schindler R, Wieters D, Grouven U, Brunkhorst R, Koch KM. Pre-transplant hypertension: a major risk factor for chronic progressive renal allograft dysfunction? Nephrol Dial Transplant 1995; 10: 1206-1211
12. Anonymous. Renal transplantation: access and outcomes. Am J Kidney Dis 1991; 18 [Suppl 2]: 61-73
13. Nevins TE, Danielson G. Prior dialysis does not affect the outcome of pediatric renal transplantation. Pediatr Nephrol 1991; 5: 211-214
14. Ekstrand A. Kidney transplantation with and without prior dialysis therapy in diabetic patients with end-stage renal failure. Scand J Urol Nephrol 1993; 27: 83-87
15. Anonymous. Survival probabilities and causes of death. Am J Kidney Dis 1991; 18 [Suppl 2]: 49-60
16. O'Donoghue D, Manos J, Pearson R et al. Continuous ambulatory peritoneal dialysis and renal transplantation: a ten-year experience in a single center. Perit Dial Int 1992; 12: 242-249
17. Nyberg G, Nilsson B, Nordén G, Karlberg I. Outcome of renal transplantation in patients over the age of 60: a case-control study. Nephrol Dial Transplant 1995; 10: 91-94
18. Pirsch JD, Stratta RJ, Armbrust MJ et al. Cadaveric renal transplantation with cyclosporine in patients more than 60 years of age. Transplantation 1989; 47: 259-261
19. Candinas D, Keusch G, Decurtins M, Bimmler D, Binswanger U, Largiadèr F. Resultate der Nierentransplantation bei Patienten über dem 60. Lebensjar R. Helv Chir Acta 1991; 58: 905-909
20. Port FK, Wolfe RA, Mauger EA, Berling DP, Jiang K. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA 1993; 270: 1339-1343
21. Kasiske BL, Ramos EL, Gaston RS et al. The evaluation of renal transplant candidates: clinical practical guidelines. J Am Soc Nephrol 1995; 6: 1-34
22. Kootte AMM, Lensen LM, van Bockel JH, van Es LA, Paul LC. High- and low-dose regimens of cyclosporin in renal transplantation: immunosuppressive efficacy and side-effects. Nephrol Dial Transplant 1988; 3: 666-670
23. Stiller CR, Opelz G. Should cyclosporine be continued indefinitely? Transplant Proc 1991; 23: 36-40
24. Paul LC, Sutherland F, Klassen J, Buckle S, Burgess E. Cardiovascular risk impact of cyclosporine immunosuppression in renal transplant recipients. Transplant Proc 1992; 24: 2740-2741
25. Florijn KW, Chang PC, van der Woude FJ, van Bockel JH, van Saase JLCM. Long-term cardiovascular morbidity and mortality in autosomal dominant polycystic kidney disease patients after renal transplantation. Transplantation 1994; 57: 73-81
26. Rischen-Vos J, van der Woude FJ, Tegzess AM et al. Increased morbidity and mortality in patients with diabetes mellitus after kidney transplantation as compared with non-diabetic patients. Nephrol Dial Transplant 1992; 7: 433-437
27. Ekberg H, Persson NH, Källén R, Omnell Persson M. Reduced patient survival in diabetic recipients of renal transplants. Transplant Proc 1994; 26: 1759-1760
28. Tang J-L, Morris JK, Wald NJ, Hole D, Shipley M, Tunstall-Pedoe H. Mortality in relation to tar yield of cigarettes: a prospective study of four cohorts. Br Med J 1995; 311: 1530-1533
29. Schaubel D, Desmeules M, Mao Y, Jeffery J, Fenton S. Survival experience among elderly end-stage renal disease patients. Transplantation 1995; 60: 1389-1394.